First insights into familial ALS in Egypt reveal genetic variations and disease progression

Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease characterized by the progressive degeneration of motor neurons, leading to muscle weakness and eventually death.

New study shows XBB.1.5 COVID-19 vaccine significantly reduces hospitalizations and ICU admissions in older adults

Study evaluates the effectiveness of the XBB.1.5 COVID-19 vaccine in reducing hospitalizations and ICU admissions among vaccinated adults aged 60 and over in the Netherlands,

December 18, 2023

Dementia and Sleep; Functional Neurologic Disorder and Long COVID; Autism-Gut Link?

The New York Times examined the complicated relationship between sleep and dementia. While a U.K. Biobank study looked at how sleep, chronotype, and other factors

July 17, 2024

Abera and Orexo partner for vaccine powder formulations

The partnership aims to develop powder formulations of the vaccine candidates against influenza by leveraging Orexo’s AmorphOX technology. Credit: Ground Picture/Shutterstock. Abera Bioscience and Orexo

December 18, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.